Haemonetics Corp. buy Mizuho
Start price
17.12.25
/
50%
€67.50
Target price
17.12.26
€76.62
Performance (%)
-9.63%
Price
05.06.26
€62.00
Summary
This prediction is currently active. With a performance of -9.63%, the BUY prediction by Mizuho is trending in the wrong direction. This prediction currently runs until 17.12.26. The prediction end date can be changed by Mizuho at any time. Mizuho has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Haemonetics Corp. | 5.983% | 5.983% |
| iShares Core DAX® | -1,86 % | -1,62 % |
| iShares Nasdaq 100 | -3,32 % | 3,32 % |
| iShares Nikkei 225® | -2,30 % | 3,44 % |
| iShares S&P 500 | -1,31 % | 2,44 % |
Comments by Mizuho for this prediction
In the thread Haemonetics Corp. diskutieren
Haemonetics (NYSE:HAE) had its price target raised by analysts at Mizuho from $75.00 to $90.00. They now have an "outperform" rating on the stock.
Ratings data for HAE provided by MarketBeat
Stopped prediction by Mizuho for Haemonetics Corp.
Haemonetics Corp.
Start price
Target price
Perf. (%)
€50.00
13.04.26
13.04.26
€59.89
13.04.27
13.04.27
23.00%
05.06.26
05.06.26
Haemonetics Corp.
Start price
Target price
Perf. (%)
€48.40
06.02.26
06.02.26
€67.86
06.02.27
06.02.27
28.10%
05.06.26
05.06.26